Enhancing Immunity Against Infections Through TIGIT Knockout

Overview

Journal mBio

Publisher American Society for Microbiology

Specialty Microbiology

Date 2024 Aug 7

PMID 39109867

Authors

Ahmed Rishiq

Mingdong Liu

Ofer Mandelboim

Affiliations

Soon will be listed here.

Abstract

Importance: Our results identify the significance of T cell immunoreceptor with immunoglobulin and ITIM domain in modulating host defense against and highlight the potential therapeutic implications for infections.

References

Schorer M, Rakebrandt N, Lambert K, Hunziker A, Pallmer K, Oxenius A . TIGIT limits immune pathology during viral infections. Nat Commun. 2020; 11(1):1288. PMC: 7062903. DOI: 10.1038/s41467-020-15025-1. View

Rishiq A, Bsoul R, Pick O, Mandelboim O . Studying TIGIT activity against tumors through the generation of knockout mice. Oncoimmunology. 2023; 12(1):2217735. PMC: 10228407. DOI: 10.1080/2162402X.2023.2217735. View

Mellinghoff S, Thelen M, Bruns C, Garcia-Marquez M, Hartmann P, Lammertz T . T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option. J Infect. 2021; 84(2):237-247. DOI: 10.1016/j.jinf.2021.12.009. View

Ramirez-Garcia A, Rementeria A, Aguirre-Urizar J, Moragues M, Antoran A, Pellon A . Candida albicans and cancer: Can this yeast induce cancer development or progression?. Crit Rev Microbiol. 2014; 42(2):181-93. DOI: 10.3109/1040841X.2014.913004. View

Netea M, Joosten L, van der Meer J, Kullberg B, van de Veerdonk F . Immune defence against Candida fungal infections. Nat Rev Immunol. 2015; 15(10):630-42. DOI: 10.1038/nri3897. View

Turnis M, Andrews L, Vignali D . Inhibitory receptors as targets for cancer immunotherapy. Eur J Immunol. 2015; 45(7):1892-905. PMC: 4549156. DOI: 10.1002/eji.201344413. View

Richardson J, Moyes D . Adaptive immune responses to Candida albicans infection. Virulence. 2015; 6(4):327-37. PMC: 4601188. DOI: 10.1080/21505594.2015.1004977. View

Zhang C, Wang H, Li J, Hou X, Li L, Wang W . Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection. Hepatology. 2021; 74(6):3376-3393. DOI: 10.1002/hep.32035. View

Prosser A, Dart S, Larma-Cornwall I, Lucas M . Flow cytometric characterization of tissue-resident lymphocytes after murine liver and heart transplantation. STAR Protoc. 2021; 2(4):100810. PMC: 8449134. DOI: 10.1016/j.xpro.2021.100810. View

10.

Wurster S, Watowich S, Kontoyiannis D . Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions. Front Immunol. 2022; 13:1018202. PMC: 9640966. DOI: 10.3389/fimmu.2022.1018202. View

11.

Sheppard D, Yeaman M, Welch W, Phan Q, Fu Y, Ibrahim A . Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem. 2004; 279(29):30480-9. DOI: 10.1074/jbc.M401929200. View

12.

Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M . Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015; 42(2):344-355. PMC: 4361732. DOI: 10.1016/j.immuni.2015.01.010. View

13.

Zunino S, Hudig D . Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun. 1988; 56(3):564-9. PMC: 259327. DOI: 10.1128/iai.56.3.564-569.1988. View

14.

Pellon A, Nasab S, Moyes D . New Insights in Innate Immunity at the Mucosa: Toxins, Epithelium, Metabolism, and Beyond. Front Cell Infect Microbiol. 2020; 10:81. PMC: 7062647. DOI: 10.3389/fcimb.2020.00081. View

15.

Hoyer L, Cota E . Candida albicans Agglutinin-Like Sequence (Als) Family Vignettes: A Review of Als Protein Structure and Function. Front Microbiol. 2016; 7:280. PMC: 4791367. DOI: 10.3389/fmicb.2016.00280. View

16.

Whibley N, Gaffen S . Brothers in arms: Th17 and Treg responses in Candida albicans immunity. PLoS Pathog. 2014; 10(12):e1004456. PMC: 4256420. DOI: 10.1371/journal.ppat.1004456. View

17.

Brown G, Herre J, Williams D, Willment J, Marshall A, Gordon S . Dectin-1 mediates the biological effects of beta-glucans. J Exp Med. 2003; 197(9):1119-24. PMC: 2193964. DOI: 10.1084/jem.20021890. View

18.

Yu D, Liu Z . The research progress in the interaction between and cancers. Front Microbiol. 2022; 13:988734. PMC: 9554461. DOI: 10.3389/fmicb.2022.988734. View

19.

Talapko J, Mestrovic T, Dmitrovic B, Juzbasic M, Matijevic T, Bekic S . A Putative Role of in Promoting Cancer Development: A Current State of Evidence and Proposed Mechanisms. Microorganisms. 2023; 11(6). PMC: 10305569. DOI: 10.3390/microorganisms11061476. View

20.

Manieri N, Chiang E, Grogan J . TIGIT: A Key Inhibitor of the Cancer Immunity Cycle. Trends Immunol. 2016; 38(1):20-28. DOI: 10.1016/j.it.2016.10.002. View